Page last updated: 2024-09-03
e 4695 and carbostyril
e 4695 has been researched along with carbostyril in 2 studies
Compound Research Comparison
| Studies (e 4695) | Trials (e 4695) | Recent Studies (post-2010) (e 4695) | Studies (carbostyril) | Trials (carbostyril) | Recent Studies (post-2010) (carbostyril) |
|---|---|---|---|---|---|
| 6 | 0 | 0 | 12,855 | 1,323 | 5,611 |
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Jones, RN | 1 |
| Barrett, MS; Erwin, ME; Gooding, BB; Johnson, DM; Jones, RN | 1 |
Other Studies
2 other study(ies) available for e 4695 and carbostyril
| Article | Year |
|---|---|
In vitro evaluation of E-4695, a new fluoro-naphthyridine.
Topics: Anti-Bacterial Agents; Azetidines; Bacteria; Ciprofloxacin; Drug Evaluation, Preclinical; Enoxacin; Fleroxacin; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Quinolones | 1992 |
Antimicrobial activities of two investigational fluoroquinolones (CI-960 and E4695) against over 100 Legionella sp. isolates.
Topics: Anti-Infective Agents; Azetidines; Fluoroquinolones; Humans; Legionella; Legionella pneumophila; Legionnaires' Disease; Naphthyridines; Quinolones; Streptococcus | 1992 |